 |
|
|
| |
SINGLE DOSES OF MK-8507, A NOVEL HIV-1 NNRTI,
REDUCED HIV VIRAL LOAD FOR AT LEAST A WEEK
|
| |
| |
HIV Glasgow (Virtual event); 5-8 October 2020
Reported by Jules Levin
Wendy Ankrom1; Dirk Schurmann2; Deanne Jackson Rudd1; Andrea Schaeffer1; Inge De
Lepeleire3; Evan J. Friedman1; Martine Robberechts3; Saijuan Zhang1; Christian Keicher2; Joerg Hofmann4; S. Aubrey Stoch1; Marian Iwamoto1
1Merck & Co., Inc., Kenilworth, NJ, USA; 2Charite Research Organisation, Berlin, Germany; 3MSD (Europe) Inc., Brussels, Belgium; 4Institute of Virology, Charite Universitatsmedizin Berlin, Berlin, Germany
|
| |
|
|
|
|
|
